Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 667,485 |
|
|||||
| News | - | ||||||
| Day High | 19.07 | Low High |
|||||
| Day Low | 18.3259 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kiniksa Pharmaceuticals Ltd | KNSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.44 | 2.37% | 19.01 | 17:16:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 18.58 | 18.3259 | 19.07 | 19.01 | 18.57 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,127 | 667,485 | $ 18.86 | $ 12,591,541 | - | 13.56 - 22.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:25:11 | 10 | $ 18.93 | USD |
Kiniksa Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.34B | 70.62M | - | 270.26M | 14.08M | 0.20 | 95.29 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kiniksa Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KNSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 19.29 | 19.52 | 18.3259 | 18.81 | 250,634 | -0.28 | -1.45% |
| 1 Month | 20.13 | 20.515 | 18.3259 | 19.63 | 274,048 | -1.12 | -5.56% |
| 3 Months | 21.40 | 21.52 | 16.56 | 19.00 | 355,217 | -2.39 | -11.17% |
| 6 Months | 15.98 | 22.10 | 15.82 | 18.94 | 405,466 | 3.03 | 18.96% |
| 1 Year | 13.73 | 22.10 | 13.56 | 17.74 | 422,117 | 5.28 | 38.46% |
| 3 Years | 13.60 | 22.10 | 7.36 | 14.36 | 393,125 | 5.41 | 39.78% |
| 5 Years | 15.30 | 33.00 | 5.01 | 15.37 | 358,424 | 3.71 | 24.25% |
Kiniksa Pharmaceuticals Description
| Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. |
